Renaissance Technologies’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.3K | Buy |
27,673
+6,200
| +29% | +$20.5K | ﹤0.01% | 3314 |
|
|
2025
Q1 | $61.4K | Buy |
21,473
+6,900
| +47% | +$19.7K | ﹤0.01% | 3269 |
|
|
2024
Q4 | $33.8K | Buy |
14,573
+3,900
| +37% | +$9.05K | ﹤0.01% | 3436 |
|
|
2024
Q3 | $33.6K | Buy |
+10,673
| New | +$33.6K | ﹤0.01% | 3387 |
|
|
2024
Q2 | – | Sell |
-68,800
| Closed | -$215K | – | 3467 |
|
|
2024
Q1 | $215K | Buy |
+68,800
| New | +$215K | ﹤0.01% | 3205 |
|
|
2023
Q4 | – | Sell |
-10,000
| Closed | -$33K | – | 3715 |
|
|
2023
Q3 | $33K | Sell |
10,000
-49,300
| -83% | -$163K | ﹤0.01% | 3460 |
|
|
2023
Q2 | $190K | Buy |
59,300
+37,998
| +178% | +$122K | ﹤0.01% | 3316 |
|
|
2023
Q1 | $92K | Sell |
21,302
-26,598
| -56% | -$115K | ﹤0.01% | 3512 |
|
|
2022
Q4 | $204K | Sell |
47,900
-9,300
| -16% | -$39.6K | ﹤0.01% | 3407 |
|
|
2022
Q3 | $281K | Sell |
57,200
-28,682
| -33% | -$141K | ﹤0.01% | 3240 |
|
|
2022
Q2 | $263K | Sell |
85,882
-138,773
| -62% | -$425K | ﹤0.01% | 3522 |
|
|
2022
Q1 | $616K | Sell |
224,655
-106,145
| -32% | -$291K | ﹤0.01% | 3047 |
|
|
2021
Q4 | $982K | Buy |
330,800
+118,600
| +56% | +$352K | ﹤0.01% | 2654 |
|
|
2021
Q3 | $1.01M | Buy |
212,200
+87,701
| +70% | +$418K | ﹤0.01% | 2543 |
|
|
2021
Q2 | $483K | Buy |
+124,499
| New | +$483K | ﹤0.01% | 2978 |
|
|
2020
Q2 | – | Sell |
-32,216
| Closed | -$51K | – | 3414 |
|
|
2020
Q1 | $51K | Buy |
+32,216
| New | +$51K | ﹤0.01% | 3320 |
|